Upward J - Search Results

1

The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteers.

Allen A, Crome P, Davie CC, Davy M, Jones RW, Pierce DM, Upward J, Wijayawardhana P. Allen A, et al. Among authors: upward j. Eur J Clin Pharmacol. 1995;48(6):519-20. doi: 10.1007/BF00194344. Eur J Clin Pharmacol. 1995. PMID: 8582473 Clinical Trial. No abstract available.

2

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects.

Allen A, Asgill CC, Pierce DM, Upward J, Zussman BD. Allen A, et al. Among authors: upward j. Eur J Clin Pharmacol. 1994;46(2):159-62. doi: 10.1007/BF00199881. Eur J Clin Pharmacol. 1994. PMID: 8039536 Clinical Trial.

3

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.

Upward JW, Arnold BD, Link C, Pierce DM, Allen A, Tasker TC. Upward JW, et al. Eur J Cancer. 1990;26 Suppl 1:S12-5. Eur J Cancer. 1990. PMID: 2169778 Clinical Trial.

4

Granisetron as antiemetic therapy in children with cancer.

Craft AW, Price L, Eden OB, Shaw P, Campbell R, Pierce DM, Murdoch R, Upward J. Craft AW, et al. Among authors: upward j. Med Pediatr Oncol. 1995 Jul;25(1):28-32. doi: 10.1002/mpo.2950250107. Med Pediatr Oncol. 1995. PMID: 7752999

5

Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers.

Brocks DR, Upward J, Davy M, Howland K, Compton C, McHugh C, Dennis MJ. Brocks DR, et al. Among authors: upward j. Br J Clin Pharmacol. 1997 Sep;44(3):289-91. doi: 10.1046/j.1365-2125.1997.00650.x. Br J Clin Pharmacol. 1997. PMID: 9296325 Free PMC article. Clinical Trial.

6

Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.

Chen C, Upward J, Arumugham T, Stier B, Davy M. Chen C, et al. Among authors: upward j. Clin Ther. 2015 Feb 1;37(2):349-57. doi: 10.1016/j.clinthera.2014.10.015. Epub 2014 Nov 20. Clin Ther. 2015. PMID: 25467190 Clinical Trial.

7

An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.

Zussman BD, Benincosa LJ, Webber DM, Clark DJ, Cowley H, Kelly J, Murdoch RD, Upward J, Wyld P, Port A, Fuder H. Zussman BD, et al. Among authors: upward j. J Clin Pharmacol. 2001 Sep;41(9):950-8. doi: 10.1177/00912700122010924. J Clin Pharmacol. 2001. PMID: 11549099 Clinical Trial.

8

The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers.

Brocks DR, Upward JW, Georgiou P, Stelman G, Doyle E, Allen E, Wyld P, Dennis MJ. Brocks DR, et al. Among authors: upward jw. Eur J Clin Pharmacol. 1996;51(3-4):303-8. doi: 10.1007/s002280050202. Eur J Clin Pharmacol. 1996. PMID: 9010703 Clinical Trial.

9

Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.

Davy M, Upward J, Arumugham T, Twomey C, Chen C, Stier B. Davy M, et al. Among authors: upward j. Clin Ther. 2013 Dec;35(12):1964-74. doi: 10.1016/j.clinthera.2013.10.011. Epub 2013 Nov 28. Clin Ther. 2013. PMID: 24290737 Clinical Trial.

10

The pharmacokinetics of pranlukast in healthy young and elderly subjects.

Brocks DR, Upward J, Hust R, Köester FE, Collie H, Qian Y, Dennis MJ. Brocks DR, et al. Among authors: upward j. Int J Clin Pharmacol Ther. 1996 Sep;34(9):375-9. Int J Clin Pharmacol Ther. 1996. PMID: 8880285

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters